Kashiv BioSciences, LLC has announced the appointment of Viet Nguyen as Chief Operating Officer and Arlene Wolny as Senior Vice President of Regulatory Affairs, reinforcing its executive leadership as the company advances its global expansion strategy. Both executives will be based in Piscataway, New Jersey, and bring extensive international experience across operations, regulatory strategy, and pharmaceutical development.
Viet Nguyen joins Kashiv with more than two decades of leadership experience in scaling complex operations and building high-performing teams. He has held senior roles across global markets, including Singapore, China, and Switzerland, working with leading organizations such as Genentech, Roche, Merck Group, and Bayer. As COO, he will oversee manufacturing, quality, supply chain, and engineering operations, supporting the company’s next phase of growth.
Arlene Wolny brings deep expertise in global regulatory affairs, with a strong track record of navigating complex approval pathways and accelerating product development timelines. She has previously held leadership roles at Biocon Biologics, Sandoz, Novartis, and Roche. At Kashiv, she will lead global regulatory strategy, focusing on advancing pipeline programs efficiently across key markets.
Dr Sandeep Athalye, Global CEO of KashivBioSciences, stated that the appointments strengthen the company’s ability to scale operations and deliver high-quality biologics to patients worldwide. He emphasized that the combined expertise of both leaders will play a critical role in driving execution and supporting the company’s long-term growth objectives.
These appointments underscore Kashiv’s commitment to building a strong leadership foundation as it expands its portfolio of biosimilars and advances clinical-stage assets. With integrated capabilities spanning research and development, manufacturing, regulatory, and intellectual property, the company is well positioned to accelerate innovation and improve access to essential medicines globally.
Kashiv BioSciences LLC is a vertically integrated biopharmaceutical organization with a strong portfolio of commercial products and advanced clinical-stage assets. It is among the few US-based companies that both manufacture biosimilars and have secured marketing authorization for multiple such products.
Operating through its US headquarters and subsidiaries in India, Kashiv BioSciences combines robust infrastructure with highly skilled teams to deliver end-to-end capabilities across research and development, clinical operations, manufacturing, regulatory affairs, and intellectual property. The company is driven by a commitment to improving patient outcomes and expanding access to essential medicines through innovation and collaboration.